Steven Sherman - Mar 8, 2022 Form 4/A - Amendment Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role: Executive Chair
Signature: /s/ Jerome Wong, as Attorney-in-Fact
Stock symbol: EKSO
Transactions as of: Mar 8, 2022
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 5/17/2023, 07:46 PM
Date Of Original Report: Mar 10, 2022
Previous filing: Jun 17, 2022
Next filing: Mar 17, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EKSO	Common Stock	Options Exercise	$0	+15.6K	+39.03%	$0.00	55.6K	Mar 8, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EKSO	Restricted Stock Units	Options Exercise	$0	-15.6K	-8.33%	$0.00	172K	Mar 8, 2022	Common Stock	15.6K		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On March 10, 2022, the Reporting Person filed a Form 4 that did not reflect the decrease in the Reporting Person's holdings caused by the Issuer's 1-for-15 reverse stock split effected on March 24, 2020. This Amendment corrects such inaccuracies.
F2	Shares represent restricted stock units ("RSUs") granted in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date"). The Issuer's Compensation Committee formally authorized the grant of such RSUs and the related RSU Agreement on March 8, 2022.
F3	The first installment of the RSUs vested on February 21, 2022 and were delivered to the Reporting Person immediately in connection with the execution of the RSU Agreement.